China
· Delayed Price · Currency is CNY Beijing Aosaikang Pharmaceutical Statistics
Total Valuation
Beijing Aosaikang Pharmaceutical has a market cap or net worth of CNY 10.14 billion. The enterprise value is 8.42 billion.
| Market Cap | 10.14B |
| Enterprise Value | 8.42B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Beijing Aosaikang Pharmaceutical has 928.16 million shares outstanding. The number of shares has increased by 19.51% in one year.
| Shares Outstanding | 928.16M |
| Shares Change (YoY) | +19.51% |
| Shares Change (QoQ) | -20.27% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 3.96% |
| Float | 172.51M |
Valuation Ratios
The trailing PE ratio is 119.47.
| PE Ratio | 119.47 |
| Forward PE | n/a |
| PS Ratio | 6.18 |
| PB Ratio | 3.12 |
| P/FCF Ratio | 49.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 202.62, with an EV/FCF ratio of 41.00.
| EV / Earnings | 98.42 |
| EV / Sales | 5.09 |
| EV / EBITDA | 202.62 |
| EV / EBIT | n/a |
| EV / FCF | 41.00 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 2.65.
| Current Ratio | 3.73 |
| Quick Ratio | 3.42 |
| Debt / Equity | 2.65 |
| Debt / EBITDA | 1.96 |
| Debt / FCF | 0.40 |
| Interest Coverage | -15.04 |
Financial Efficiency
Return on equity (ROE) is 1.28% and return on invested capital (ROIC) is -0.87%.
| Return on Equity (ROE) | 1.28% |
| Return on Assets (ROA) | -0.75% |
| Return on Capital (ROIC) | -0.87% |
| Revenue Per Employee | 1.69M |
| Profits Per Employee | 87,351 |
| Employee Count | 979 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.21% in the last 52 weeks. The beta is 0.35, so Beijing Aosaikang Pharmaceutical's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +40.21% |
| 50-Day Moving Average | 10.37 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 50.26 |
| Average Volume (20 Days) | 3,896,771 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Aosaikang Pharmaceutical had revenue of CNY 1.65 billion and earned 85.52 million in profits. Earnings per share was 0.09.
| Revenue | 1.65B |
| Gross Profit | 1.35B |
| Operating Income | -42.28M |
| Pretax Income | 50.41M |
| Net Income | 85.52M |
| EBITDA | 39.06M |
| EBIT | -42.28M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 1.95 billion in cash and 81.50 million in debt, giving a net cash position of 1.87 billion or 2.01 per share.
| Cash & Cash Equivalents | 1.95B |
| Total Debt | 81.50M |
| Net Cash | 1.87B |
| Net Cash Per Share | 2.01 |
| Equity (Book Value) | 3.08B |
| Book Value Per Share | 3.50 |
| Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was 366.29 million and capital expenditures -161.03 million, giving a free cash flow of 205.26 million.
| Operating Cash Flow | 366.29M |
| Capital Expenditures | -161.03M |
| Free Cash Flow | 205.26M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 81.38%, with operating and profit margins of -2.56% and 5.17%.
| Gross Margin | 81.38% |
| Operating Margin | -2.56% |
| Pretax Margin | 3.05% |
| Profit Margin | 5.17% |
| EBITDA Margin | 2.36% |
| EBIT Margin | -2.56% |
| FCF Margin | 12.41% |
Dividends & Yields
Beijing Aosaikang Pharmaceutical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.28% |
| Buyback Yield | -19.51% |
| Shareholder Yield | -19.51% |
| Earnings Yield | 0.84% |
| FCF Yield | 2.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |